Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Finasteride shows promise for female hair loss, but more research needed.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Hair loss doesn't affect COVID-19 severity.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.